Method has been experimenting with Artificial Intelligence, connected devices (IoT), as well as exploring the value of data as a raw material for design. We hypothesized that a software platform could be designed to help improve the persistent challenges associated with treatment adherence, framing our thinking through the design and development of a speculative healthcare service we’ve named Nightingale.
Experimenting with current developments in AI helped us to design a more tailored experience for users, as well as helped create an interface that’s sympathetic to their unique set of medical and personal needs. Prototyped pharmaceutical packaging is able to infer if a dose has been taken and transmits this information to the cloud.
By augmenting "everyday objects" to “nudge” users while complementing existing behavior patterns, Nightingale delivers welcome reminders across multiple devices that helps to create unique and contextual experiences for users in their own home.
Human-centered design is the foundation for healthcare products and services
Among individuals with chronic illness, more than 50% don’t take medications as prescribed, and it’s commonly believed among medical experts that improving treatment adherence could have far greater impact on the health of the population than any specific medical treatment.
Today's ever more complicated medical regimens, combined with overworked healthcare providers, make it even less likely that physicians will be able to enforce adherence. And treating asymptomatic conditions and encouraging dietary or lifestyle changes as part of a treatment present an even greater problem.
Ultimately the project was an exercise to help us explore the challenges of designing products and services that are data-centric irrespective of device and medium. More importantly, Nightingale explores how design solutions can be the foundation for those products and services to cater to individual people and fit in to their lives.